MedTech Dive September 16, 2024
Private equity could be “the most likely” buyer of the eye care business, analysts wrote.
Dive Brief:
- Bausch + Lomb is exploring a potential sale that would separate the eye care company from parent firm Bausch Health, the Financial Times reported on Saturday, citing unnamed sources.
- A private equity firm could be a likely buyer, J.P. Morgan and Needham analysts wrote in research notes. “There are only a few strategics that would make sense, in our view, and all would likely run into anti-trust challenges,” Needham analyst David Saxon wrote in a Monday note to clients.
- Bausch + Lomb received interest from private equity firms before it went public in 2022, the Financial Times reported. A company spokesperson wrote...
Today's Sponsors
Today's Sponsor